# BCN Peptides SA – FDA Inspection, Mar 15, 2019

Source: https://www.keypedia.com/records/fda_inspections/bcn-peptides-sa/e9376b15-28bf-41c5-9574-806490d1bc08
Source feed: FDA_Inspections

> FDA inspection 1112160 of BCN Peptides SA, March 15, 2019. Classification: Voluntary Action Indicated (VAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1112160
- Company Name: BCN Peptides SA
- Inspection Date: 2019-03-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1287710 - 2023-10-09
- FDA Inspection 1110777 - 2019-10-18
- FDA Inspection 917366 - 2015-01-16
- FDA Inspection 787875 - 2012-04-26
- FDA Inspection 659207 - 2010-03-18

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/bcn-peptides-sa/b0fa0b1d-5597-4653-9d34-ae9ab14d2de3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
